Curriculum Vitae

Nikola Panajotovikj

PhD Researcher

Education

University of Girona

Sept 2024 - Present

PhD in Computational Chemistry

Pompeu Fabra University, Barcelona

Sept 2022 - July 2024

MSc in Bioinformatics for Health Sciences, average grade: 9.31/10

University Ss. Cyril and Methodius, Skopje

Sept 2018 - Jun 2022

BSc in Molecular Biology and Genetics, summa cum laude: 9.91/10

Work Experience

Jul 2023 - Present

Pharmacovigilance Researcher

Analyze post-marketing drug safety data using spontaneous reporting systems, SQL, and Python. Query and interpret information from regulatory bodies including FDA and EMA, and prepare reports and presentations for internal safety assessments.

  • Presented a poster at the MainFrame Symposium 2025.
  • Presented pharmacovigilance posters and contributed to event organization at EuroQSAR 2024.
  • Participated in the ISoP mid-year symposium 2024.

Macedonian Academy of Sciences and Arts

Jan 2022 - Sep 2022

Whole Exome Sequencing Data Researcher

Developed an R pipeline for whole exome sequencing data and worked with sequencing-related instrumentation including NextSeq 550, MiSeq, Genetic Analyzer, Real-Time PCR systems, and Bioanalyzer.

University Ss. Cyril and Methodius

Sept 2021 - Jan 2022

Teacher's Assistant, Department of Biochemistry

Led practical sessions for Basics in Biochemistry, guided students through lab experiments, evaluated performance, assisted with exams, and contributed to research on antioxidant capacity of Ganoderma mushrooms.

University Ss. Cyril and Methodius

Jun 2020 - Aug 2021

Laboratory Technician, Department of Genetics

Managed administrative responsibilities, processed student files, supervised exams, and contributed to research on the cytotoxic effects of insecticides, pesticides, and supplements on the apical root meristem of Zea mays.

Projects

Feb 2025 - Present

Drug Safety and Risk Management Researcher

Contribute to research activities focused on indication-specific drug safety and repurposing. Support the design of methods for safety signal detection, evidence integration, and prioritization of repurposing opportunities.

  • Presented on post-marketing safety in repurposed drugs at the REMEDi4ALL Hackathon 2025 in Barcelona.
  • Participated in consortium sessions and technical discussions at the Fourth General Assembly Meeting in Ljubljana.
  • Presented a poster on indication-specific drug safety at the International Drug Repurposing Conference in Amsterdam.

Selected Publications

  • Huiyan Ying, Weikaixin Kong, Aron Schulman, Nikola Panajotovikj, Mirva Paakkonen, Tanisha Malpani, Ziaurrehman Tanoli, Otto Kauko, Jordi Mestres, Tero Aittokallio, Mitro Miihkinen. Off-target mapping enhances selectivity of machine learning-predicted CK2 inhibitors. [In Review] bioRxiv 2025.11.12.688093. DOI: doi.org/10.1101/2025.11.12.688093
  • Panajotovikj, N., Fernandez-Torras, A. & Mestres, J. Drug safety in healthy aging. npj Aging 11, 28 (2025). DOI: doi.org/10.1038/s41514-025-00220-5
  • Nikola Panajotovikj, A. Fernandez-Torras and R. Garcia-Sern et al. Safety Signal Detection and Patient Profile Heterogeneity in Multiple Indication Drugs. 2025. DOI: doi.org/10.14293/iDR.25.008NP

Scholarships

Scholarship of the Ministry of Education and Science for Studies Outside of Macedonia

2022 - 2024

University Tuition Fee Waiver for Exceptionally High Academic Achievements

2019 - 2022

Scholarship of the Ministry of Education and Science for Intellectually Gifted Students

2019 - 2022

Languages

  • English - C2, Cambridge English Level 3 Certificate in ESOL International
  • Spanish - B2 level of understanding
  • Catalan - B1 level of understanding